Photoacoustic Spectral Analysis for Evaluating the Aggressiveness of Prostate Cancer Labeled by Methylene Blue Polyacrylamide Nanoparticles
Biosensors · 20.03.2023 · 13 (3) · 403
DOI: 10.3390/bios13030403 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors, online erschienen am 20.03.2023. Verfasst von Janggun Jo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109, USA. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Nanoparticles, Photoacoustic Techniques. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Institute of Health, Prostate Cancer Foundation.
Abstract (Originalsprache)
Evaluating the aggressiveness of prostate cancer (PCa) is crucial for PCa diagnosis and prognosis. Previously, studies have shown that photoacoustic spectral analysis (PASA) can assess prostate tissue microarchitecture for evaluating the aggressiveness of PCa. In this study, in a transgenic mouse (TRAMP) model of PCa, we utilized methylene blue polyacrylamide nanoparticles (MB PAA NPs) to label the cancer cells in prostate in vivo. MB PAA NPs can specifically target proliferating cancer cells as a contrast agent, allowing photoacoustic (PA) imaging to better detect PCa tumors, and also assessing prostate glandular architecture. With the PA signals from the prostates measured simultaneously by a needle hydrophone and a PA and ultrasound (US) dual-imaging system, we conducted PASA and correlated the quantified spectral parameter slopes with the cancer grading from histopathology. The PASA results from 18 mice showed significant differences between normal and cancer, and also between low-score cancer and high-score cancer. This study in the clinically relevant TRAMP model of PCa demonstrated that PA imaging and PASA, powered by MB PAA NPs that can label the PCa microarchitectures in vivo after systemic administration, can detect PCa and, more importantly, evaluate cancer aggressiveness.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109, USA.
- Department of Chemistry, University of Michigan, Ann Arbor, MI 48109, USA.
- Department of Pathology, University of Michigan Health System, Ann Arbor, MI 48109, USA.
- Department of Urology, University of Michigan, Ann Arbor, MI 48109, USA.
- Department of Biomedical Engineering, Pennsylvania State University, University Park, PA 16801, USA.
- Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, MI 48109, USA.
ORCID-Profile: Jeff Folz, Aaron M Udager, Sri-Rajasekhar Kothapalli
Förderung
- NCI NIH HHS
- National Institute of Health
- Prostate Cancer Foundation
- NIDDK NIH HHS
- National Cancer Institute
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Jo, J., Salfi, E., Folz, J., Udager, A. M., Keller, E., Kopelman, R., Kothapalli, S. R., Xu, G., & Wang, X. (2023). Photoacoustic Spectral Analysis for Evaluating the Aggressiveness of Prostate Cancer Labeled by Methylene Blue Polyacrylamide Nanoparticles. Biosensors, 13(3), 403. https://doi.org/10.3390/bios13030403
Vancouver
Jo J, Salfi E, Folz J, Udager AM, Keller E, Kopelman R, et al. Photoacoustic Spectral Analysis for Evaluating the Aggressiveness of Prostate Cancer Labeled by Methylene Blue Polyacrylamide Nanoparticles. Biosensors. 2023;13(3):403. doi:10.3390/bios13030403
BibTeX
@article{Jo2023,
author = {Jo, Janggun and Salfi, Eamon and Folz, Jeff and Udager, Aaron M and Keller, Evan and Kopelman, Raoul and Kothapalli, Sri-Rajasekhar and Xu, Guan and Wang, Xueding},
title = {Photoacoustic Spectral Analysis for Evaluating the Aggressiveness of Prostate Cancer Labeled by Methylene Blue Polyacrylamide Nanoparticles},
journal = {Biosensors},
year = {2023},
volume = {13},
number = {3},
pages = {403},
doi = {10.3390/bios13030403}
}
EUVIMED